Suven Life Sciences Ltd to present seven CNS research posters at Neuroscience 2026
- The Society for Neuroscience annual meeting runs November 14–18 in Washington, DC.
- Posters cover clinical and preclinical programs in Alzheimer’s disease, agitation, schizophrenia, narcolepsy, sleep disorders, major depressive disorder and Parkinson’s disease; featured candidates include masupirdine, samelisant, ropanicant and tenaclidine.
